advanced nsclc: refining clinical pathways in the rapidly evolving therapeutic landscape
Published 3 years ago • 3.9K plays • Length 44:56Download video MP4
Download video MP3
Similar videos
-
34:38
strategies for nsclc: clinical pathways in the era of biomarker-driven care
-
33:23
improving survival and managing costs in nsclc: the role of clinical care pathways
-
22:06
basics of immunotherapy in nsclc
-
17:10
sclc: therapeutic progress or mirage?
-
32:12
immunotherapy updates in nsclc: front line therapy
-
2:06
evolving treatment landscape in locally advanced nsclc
-
2:56
current therapeutic landscape for small-cell lung cancer
-
1:10:25
how to select the right immunotherapy for first-line treatment of advanced nsclc
-
3:53
stages of lung cancer|survival rate & prognosis of lung cancer|dr.sandeep nayak & dr.sreekanth reddy
-
13:18
nsclc: how to handle alk resistance
-
26:13
therapeutic algorithm for nsclc adenocarcinoma
-
16:35
heterogeneity of nsclc and precipitating oncogenic driver mutations
-
38:01
integrating therapeutic advances and stakeholder perspectives into nsclc clinical pathways
-
22:06
the basics of immunotherapy in non-small cell lung cancer (nsclc)
-
7:00
landscape of biomarker testing for nsclc
-
0:46
improving lung cancer care pathways: the nlca and the nolcp
-
13:26
debate: drug of choice for exon 19 del egfr mutant nsclc - any egfr tki
-
14:00
locally advanced nsclc - state of systemic therapy
-
1:56
recent approvals in the nsclc treatment landscape
-
20:17
current controversies in small cell lung cancer (sclc)